Masato Miyauchi

Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom.

Mizuho Securities Co., Ltd. (Broker) (Mizuho Securities-Broker) is the brokerage division of Mizuho Securities Co. Ltd., ultimately owned by Mizuho Financial Group, Inc. (TYO: 8411; NYSE: MFG) in Japan. The firm was originally founded in 1917 and is headquartered in Tokyo with a network of offices throughout Japan as well as overseas representation through Mizuho entities or strategic partners (in Great Britain, Switzerland, the US, Hong Kong, Mainland China, South Korea, Singapore and India). Mizuho Securities-Broker provides enhanced equity and fixed income execution services for their clients who includes private individuals in Japan, domestic and foreign institutions, non-financial companies, financial institutions and public corporations in the securities and investment banking fields.

Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan.

SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe.